Gastric cancer remains one of the leading causes of cancer-related death worldwide, and surgical resection with lymphadenectomy is the only potentially curative option. Lymphadenectomy—the systematic ...
First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): ...
At present, the risk factors for lymph node metastasis in early gastric signet ring cell carcinoma (SRCC) remain unclear. However, it is worth noting that the LNM rate and prognosis of early gastric ...
Fluorescence-guided lymphadenectomy after neoadjuvant chemotherapy was linked to improved survival in gastric cancer. It was also significantly associated with more retrieved lymph nodes. The 3-year ...
Phase II study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO ...
Adhering to the current guideline standard for intraoperative nodal assessment in resected non–small cell lung cancer (NSCLC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results